论文信息 - Ef ﬁ cacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study - 字舞流文

Ef ﬁ cacy and Safety of the Glucagon Receptor Antagonist RVT-1502 in Type 2 Diabetes Uncontrolled on Metformin Monotherapy: A 12-Week Dose-Ranging Study

J. Rosenstock | J. Frias | J. Pettus | E. Vajda | J. Pipkin | K. Marschke | L. Zhi | Jeremy H. Pettus | D David | Alessio | Juan P. Frias | Eric G. Vajda | James D. Pipkin | Julio Rosenstock | Gretchen Williamson | Miriam A. Zangmeister | Lin Zhi | Keith B. Marschke | Miriam A. Zangmeister | Gretchen Williamson | D. David | Alessio